In the past decades, the expanding use of prostate-specific membrane antigen (PSMA)
imaging for prostate cancer has led to the incidental detection of a lot of extra-prostatic …

Purpose: Prostate specific membrane antigen is expressed by the endothelium of many
tumors. The aim of the study was to find a rationale for prostate specific membrane antigen …

Background Prostate-specific membrane antigen (PSMA) is overexpressed in the
neovasculature of renal cell carcinoma (RCC). However, there remains limited evidence …

Metastatic renal cell carcinoma (mRCC) is a disease that portends poor prognosis despite
an increasing number of novel systemic treatment options including new targeted therapies …

Although the vast majority of prostate-specific membrane antigen (PSMA) positron emission
tomography (PET) imaging occurs in the field of prostate cancer, PSMA is also highly …

Simple Summary Current imaging techniques do not reliably distinguish renal cell
carcinoma from other renal diseases. This review summarizes recent advances in other …

In recent years, small-molecule inhibitors of prostate-specific membrane antigen (PSMA)
labeled with radionuclides that allow for positron emission tomography (PET) imaging have …

Objective Complete surgical resection of metastatic sites has been shown to prolong
survival in select patients with oligometastatic RCC. This treatment strategy is dependent …

Purpose To investigate the utility of prostate-specific membrane antigen (PSMA)-targeted
[18 F] DCFPyL positron emission tomography (PET)/X-ray computed tomography (CT) …

Abstract Purpose of Review To critically review the potential clinical applications of prostate-
specific membrane antigen (PSMA) radioactive ligands in renal cell carcinoma (RCC) …